In the current scenario of COVID-19, Cricothyrotomy kit is considered as one of the critical products for immediate supply. But with the decline in the global supply chains of Cricothyrotomy kit, meeting the demand right on time would be challenging.
To ensure the world sustain the ever-growing demand in this time of emergency, as a prominent Cricothyrotomy kit manufacturer, you might be willing to market your product across the globe or to be specific in Belgium. But do you know how Cricothyrotomy kit is classified in Belgium by the Federal Agency for Medicines and Health Products (FAMHP)? How FAMHP regulates surgical Cricothyrotomy kits?
Have all your questions answered regarding:
- Cricothyrotomy kit Registration/notification in Belgium
- FAMHP Cricothyrotomy kit Regulations
In addition, some global health authorities have already expedited their Regulatory pathways for Cricothyrotomy kit. The dynamic nature of those developments might require manufacturers to be more attentive on the regional Regulatory aspects, too. In such a case, streamline Cricothyrotomy kit global market entry with the best of regional Regulatory information and structural Regulatory approach.
As a responsible Regulatory partner, Freyr has already started assisting clients to accelerate and fast track registrations/notifications of Cricothyrotomy kit in Belgium.